Products

Targeted portfolio

A unique portfolio of high quality and difficult-to-make pharmaceutical products fuels our targeted growth strategy. Alvogen has over 200 strategically selected pharmaceutical projects in development and registrations and over 350 marketed products.

More

Company

Who we are

Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, OTC and biosimilar products around the world. The company has commercial operations in 35 countries with 2,600 employees.

More

Newsroom

And the winner is … Alvogen again!

Alvogen continues to set the standard for excellence in the pharma industry, as it picked up two additional awards at the HDA's 2017 Business and Leadership Conference in Phoenix, Arizona.

Read More

Meet management

Leadership team

Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safely to market.

Meet management